VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 90 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,764,643 | -4.7% | 962,493 | +47.8% | 0.03% | 0.0% |
Q2 2023 | $15,491,548 | -3.2% | 651,179 | +3.5% | 0.03% | -11.8% |
Q1 2023 | $16,009,901 | -10.4% | 629,320 | +2.9% | 0.03% | -15.0% |
Q4 2022 | $17,860,658 | +43.1% | 611,457 | +0.5% | 0.04% | +48.1% |
Q3 2022 | $12,483,000 | +142.6% | 608,662 | +36.8% | 0.03% | +145.5% |
Q2 2022 | $5,145,000 | +1478.2% | 444,799 | +2432.6% | 0.01% | +1000.0% |
Q1 2022 | $326,000 | -81.4% | 17,563 | -80.1% | 0.00% | -66.7% |
Q4 2021 | $1,748,000 | – | 88,405 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |